TALEN

TALEN1-rragca

ID

ZDB-TALEN-220325-1

Name

TALEN1-rragca

Previous Names

None

Target

rragca (1)

Target Sequence 1

5' - AATGGGGTTGAGGAGGA - 3'

Target Sequence 2

5' - TTCCTCCTACCTTCTGG - 3'

Disclaimer

Although ZFIN verifies reagent sequence data, we recommend that you conduct independent sequence analysis before ordering any reagent.

Note

None

Genome Resources

None

Target Location

Constructs

No data available

Genomic Features

Genomic Feature	Affected Genomic Regions
xu087	rragca
xu088	rragca
xu089	rragca

Expression

Gene expression in Wild Types + TALEN1-rragca

No data available

Phenotype

Phenotype resulting from TALEN1-rragca

No data available

Phenotype of all Fish created by or utilizing TALEN1-rragca

Phenotype	Fish	Conditions	Figures
heart lamp1b expression decreased amount, abnormal	rragca^xu087/xu087 (WIK)	standard conditions	Figure 5 from Kim et al., 2021
heart atg9b expression decreased amount, abnormal	rragca^xu087/xu087 (WIK)	standard conditions	Figure 5 from Kim et al., 2021
myocardium glycogen granule increased amount, abnormal	rragca^xu087/xu087 (WIK)	standard conditions	Figure 5 from Kim et al., 2021
whole organism viability, abnormal	rragca^xu087/xu087 (WIK)	standard conditions	Figure 1 , Figure 6 , Figure 7 from Kim et al., 2021
cardiac ventricle increased size, abnormal	rragca^xu087/xu087 (WIK)	standard conditions	Figure 2 from Kim et al., 2021
heart atg9a expression decreased amount, abnormal	rragca^xu087/xu087 (WIK)	standard conditions	Figure 5 from Kim et al., 2021
autophagy decreased occurrence, abnormal	rragca^xu087/xu087 (WIK)	chemical treatment by injection: bafilomycin A1	Figure 5 from Kim et al., 2021
heart uvrag expression decreased amount, abnormal	rragca^xu087/xu087 (WIK)	standard conditions	Figure 5 from Kim et al., 2021
whole organism decreased weight, abnormal	rragca^xu087/xu087 (WIK)	standard conditions	Figure 1 from Kim et al., 2021
muscle cell decreased mass density, abnormal	rragca^xu087/xu087 (WIK)	standard conditions	Figure 2 from Kim et al., 2021
heart contraction decreased efficacy, abnormal	rragca^xu087/xu087 (WIK)	chemical treatment by injection: bafilomycin A1	Figure 5 from Kim et al., 2021
heart myh7 expression increased amount, abnormal	rragca^xu087/xu087 (WIK)	standard conditions	Figure 2 , Figure 5 , Figure 6 from Kim et al., 2021
heart vps11 expression decreased amount, abnormal	rragca^xu087/xu087 (WIK)	standard conditions	Figure 5 from Kim et al., 2021
heart Ab6-ub labeling decreased amount, abnormal	rragca^xu087/xu087 (WIK)	chemical treatment by injection: bafilomycin A1	Figure 5 from Kim et al., 2021
swimming decreased efficacy, abnormal	rragca^xu087/xu087 (WIK)	standard conditions	Figure 1 from Kim et al., 2021
heart Ab6-ub labeling decreased amount, abnormal	rragca^xu087/xu087 (WIK)	standard conditions	Figure 5 from Kim et al., 2021
heart contraction decreased efficacy, abnormal	rragca^xu087/xu087 (WIK)	standard conditions	Figure 2 , Figure 6 from Kim et al., 2021
autophagy decreased occurrence, abnormal	rragca^xu087/xu087 (WIK)	standard conditions	Figure 5 from Kim et al., 2021
heart myh7 expression increased amount, abnormal	rragca^xu087/xu087; mtor^xu015Gt/+ (WIK)	standard conditions	Figure 6 from Kim et al., 2021
whole organism viability, abnormal	rragca^xu087/xu087; mtor^xu015Gt/+ (WIK)	standard conditions	Figure 6 from Kim et al., 2021
heart contraction decreased efficacy, abnormal	rragca^xu087/xu087; mtor^xu015Gt/+ (WIK)	standard conditions	Figure 6 from Kim et al., 2021
whole organism viability, ameliorated	rragca^xu087/xu087; xu090Tg (WIK)	standard conditions	Figure 7 from Kim et al., 2021
heart contraction process efficacy, ameliorated	rragca^xu087/xu087; xu090Tg (WIK)	standard conditions	Figure 5 from Kim et al., 2021
heart myh7 expression amount, ameliorated	rragca^xu087/xu087; xu090Tg (WIK)	standard conditions	Figure 5 from Kim et al., 2021

Citations